Teva Pharmaceutical Industries Ltd. (NYSE: TEVA) released its most recent earnings report before the markets opened on Thursday. The pharma giant said that it had $0.68 in earnings per share (EPS) and $4.5 billion in revenue, while Thomson Reuters consensus estimates had called for $0.54 in EPS and revenue of $4.53 billion. The third quarter from last year reportedly had EPS of $1.00 on $5.61 billion in revenue.
The firm saw a revenue drop year over year, mainly due to generic competition to Copaxone, price erosion in its U.S. generics business and loss of revenues following the divestment of certain products and discontinuation of certain activities.
Looking ahead to the 2018 full year, the company expects to see EPS in the range of $2.80 to $2.95 and free cash flow of $3.6 billion to $3.8 billion. This is up from previous estimates of $2.55 to $2.80 in EPS and $3.2 billion to $3.4 billion in free cash flow.
Consensus estimates call for $2.78 in EPS and $18.86 billion in revenue for the full year.
Kåre Schultz, Teva’s president and CEO, commented:
I am very satisfied with our progress and we are meeting all our key targets. We received FDA approval for Aiovy in September for the preventive treatment of migraine and we are seeing very good signs of a successful launch. We continue to see strong growth for Austedo, while Copaxone continues to maintain its market share. Our restructuring plan has already resulted in a significant cost reduction of $1.8 billion in the first nine months of the year and we are on track to achieve a reduction of $3.0 billion by the end of 2019, while continuing to pay down our debt. Given the solid third quarter results, we have decided to raise our 2018 full year guidance.
Shares of Teva traded up more than 9% early Thursday at $21.86, in a 52-week range of $10.85 to $25.96. The stock’s consensus analyst price target is $21.53.
Are You Still Paying With a Debit Card?
The average American spends $17,274 on debit cards a year, and it’s a HUGE mistake. First, debit cards don’t have the same fraud protections as credit cards. Once your money is gone, it’s gone. But more importantly you can actually get something back from this spending every time you swipe.
Issuers are handing out wild bonuses right now. With some you can earn up to 5% back on every purchase. That’s like getting a 5% discount on everything you buy!
Our top pick is kind of hard to imagine. Not only does it pay up to 5% back, it also includes a $200 cash back reward in the first six months, a 0% intro APR, and…. $0 annual fee. It’s quite literally free money for any one that uses a card regularly. Click here to learn more!
Flywheel Publishing has partnered with CardRatings to provide coverage of credit card products. Flywheel Publishing and CardRatings may receive a commission from card issuers.
Thank you for reading! Have some feedback for us?
Contact the 24/7 Wall St. editorial team.
Latest from 24/7
Our expert who first called NVIDIA in 2009 is predicting 2025 will see a historic AI breakthrough.
You can follow him investing $500,000 of his own money on our top AI stocks for free.